Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival
World Journal of Urology · 2025-09-24 · 43 (1)
DOI: 10.1007/s00345-025-05948-z ↗At a glance
Journal article in World Journal of Urology, published online on 2025-09-24. Written by Stephen Baug and 5 co-authors. Institution: Department of Urology, Haraldsplass Deaconess Hospital, Bergen, Norway. Major MEDLINE topics: Transurethral Resection of Prostate, Prostatic Hyperplasia, Postoperative Complications. Cited 7 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Bergen.
Abstract (original language)
Introduction
There are few studies evaluating the outcomes associated with transurethral resection of the prostate (TURP) in extremely elderly men. Our objective was to assess the safety and efficacy of this procedure in this special population.
Methods
As part of an ethically approved study, retrospective review was carried out of all patients ≥ 85 years who underwent TURP between 2014 and 2023 at a tertiary centre. Data was collected on demographics including frailty status, operative data and complications. Treatment success was defined as catheter free status.
Results
Over the study period, 194 patients (median age 87 years, IQR 86–89) underwent TURP, with a median follow-up of 6 years (IQR 3.5–8). The majority (68%) were ASA 3. 28% received home nursing assistance or were nursing home residents at the time of surgery. Median CCI score was 2 (IQR 1–3). 66% used anticoagulant medication. 97% received spinal anaesthesia and median operative time was 63 min (IQR 39–88). The intra-operative complication rate was 2.6%. The 30-day complication rate was 30% (Clavien-Dindo (CD) 1–2: 24%, ≥ CD 3: 5.7%). Among those with a catheter preoperatively (62%, n = 120), 84% had achieved spontaneous voiding (n = 101) at three month follow up. Overall, 93% were still alive at 1 year post surgery. The cumulative reoperation rate during study follow up was 7.2% at 1 year, 10.9% at 3 years, and 11.5% at 5 years.
Conclusion
Treatment success for TURP in extremely elderly men (≥ 85 years) is high, but the associated morbidity burden warrants the need for an individualised approach when considering men in this special population who are potential candidates for surgery.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Urology, Haraldsplass Deaconess Hospital, Bergen, Norway.
- Department of Urology, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- The CRANE collaboration, Bergen, Norway.
- Department of Urology, Haukeland University Hospital, Bergen, Norway. jonesurology@gmail.com.
- Department of Clinical Medicine, University of Bergen, Bergen, Norway. jonesurology@gmail.com.
Funding
- University of Bergen
Cite
APA
Baug, S., Beisland, C., Moen, C. A., Odland, P., Blomquist, J., & Juliebø-Jones, P. (2025). Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival. World Journal of Urology, 43(1). https://doi.org/10.1007/s00345-025-05948-z
Vancouver
Baug S, Beisland C, Moen CA, Odland P, Blomquist J, Juliebø-Jones P. Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival. World Journal of Urology. 2025;43(1). doi:10.1007/s00345-025-05948-z
BibTeX
@article{Baug2025,
author = {Baug, Stephen and Beisland, Christian and Moen, Christian Arvei and Odland, Per and Blomquist, Jesper and Juliebø-Jones, Patrick},
title = {Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival},
journal = {World Journal of Urology},
year = {2025},
volume = {43},
number = {1},
doi = {10.1007/s00345-025-05948-z}
}
EUVIMED